Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Deciphera Pharmaceuticals, Inc.
| Metric | Deciphera Pharmaceuticals, Inc. Healthcare |
|---|---|
| Quality Score | 55 / 100 |
| Revenue (latest) | $163M |
| Net income (latest) | −$195M |
| Operating margin | −129.1% |
| Net margin | −119.3% |
| Return on equity | −55.6% |
| Return on assets | −41.2% |
| Return on capital (ROCE) | −56.5% |
| Debt / equity | 0.35× |
| Revenue growth (YoY) | 21.9% |
| Altman Z″ (distress) | -5.93 |
| Accruals / assets | −10.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.